
zzso are frequently used by zzso care specialists to treat zzso In this study, we determined the median daily zzso dose and prescription pattern in a cohort of zzso advanced cancer zzso with zzso 

We zzso reviewed the charts of 100 consecutive patients admitted to our acute zzso care unit with zzso for zzso zzso zzso and zzso use during the first five days of zzso The dose of zzso was expressed using the concept of zzso equivalent daily dose zzso 

The median zzso duration was six days, and the median Memorial zzso Assessment zzso on day 1 was zzso zzso of zzso included zzso zzso percent), mixed zzso percent), and zzso (10 zzso zzso olanzapine, and zzso were given to 94 zzso percent), 8 (8 percent), and 5 (5 percent) of patients, zzso The median five-day average zzso was zzso zzso zzso range zzso zzso zzso was not associated with any clinical characteristics except zzso zzso Among the 31 occasions in which zzso or zzso breakthrough doses were given in a day, only 9 (29 percent) resulted in an increase in the scheduled zzso dose, and 1 (3 percent) resulted in the addition of a new zzso the next zzso Among the 73 patients with 24 days of delirium, only 49 zzso percent) had an increase in the zzso dose, and 2 (3 percent) had a new zzso zzso 

zzso was lower than doses reported in previous studies involving cancer patients and was adjusted zzso Prospective clinical trials are necessary to identify the optimal zzso dose for zzso 

